Survodutide

Survodutide Research Material — Buy Survodutide (GLP-1/Glucagon Receptor Dual Agonist) (≥97% Purity)

Survodutide is a long-acting, fatty-acid conjugated research material studied as a dual agonist of the GLP-1 and glucagon receptors. It represents the newer generation of multi-receptor metabolic research materials being investigated for their combined incretin and glucagon-receptor-mediated effects on energy balance, distinguishing it from single-target GLP-1 agonists.

Mechanism of Action

Survodutide activates both the GLP-1 receptor and the glucagon receptor. GLP-1 receptor agonism contributes incretin-mediated effects — slowed gastric emptying, glucose-dependent insulin secretion, and appetite suppression — while glucagon receptor agonism is studied for its role in increasing hepatic fat oxidation and resting energy expenditure. This dual mechanism is a major focus of current comparative research against single-pathway metabolic research materials.

Research Applications

• Dual-receptor (GLP-1/glucagon) agonist pharmacology research
• Energy expenditure and hepatic fat oxidation studies
• Obesity and NAFLD/NASH preclinical models
• Glucose homeostasis and incretin pathway research
• Comparative studies against single-target GLP-1 and triple-agonist compounds

Specifications

• Chemical Name: Survodutide (GLP-1/Glucagon Receptor Dual Agonist)
• CAS Number: 2381089-83-2
• Molecular Formula: Complex fatty-acid conjugated research material (proprietary modified sequence)
• Molecular Weight: ≈4.7 kDa
• Sequence: Modified/acylated research material backbone — full sequence proprietary
• Purity: ≥97% (HPLC verified)
• Form: Lyophilized powder
• Available Sizes: 10mg

Storage & Handling

Store lyophilized Survodutide at −20°C, protected from light and moisture. Once reconstituted with bacteriostatic water, store at 4°C and use within 28 days. All handling should be performed under sterile laboratory conditions by trained research personnel.

For in-vitro laboratory research use only. Not for human or animal consumption. Not a drug, supplement, or medicinal product.